A novel protein glycan biomarker and LCAT activity in metabolic syndrome

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2362|45|8|850-859

ISSN： 0014-2972

Source： EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (ELECTRONIC), Vol.45, Iss.8, 2015-08, pp. : 850-859

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Physical activity in prevention and treatment of the metabolic syndrome

By Lakka Timo A.   Laaksonen David E.  

Applied Physiology, Nutrition, and Metabolism, Vol. 32, Iss. 1, 2007-02 ,pp. : 76-88

NRC Research Press

Access to resources Recommend Favorite

Association of metabolic syndrome with reduced central serotonergic activity

By Herrera-Marquez Rocio  

Metabolic Brain Disease, Vol. 26, Iss. 1, 2011-03 ,pp. : 29-35

Springer Publishing Company

Access to resources Recommend Favorite

Sleep Duration, Physical Activity, and Metabolic Syndrome for Adolescents

By Kawada Tomoyuki  

Annals of Behavioral Medicine, Vol. 46, Iss. 3, 2013-12 ,pp. : 401-402

Springer Publishing Company

Access to resources Recommend Favorite

Cell-Free Circulating DNA as a Novel Biomarker in Patients with the Acute Coronary Syndrome

By  

Cardiology, Vol. 126, Iss. 2, 2013-08 ,pp. : 122-123

Karger

Access to resources Recommend Favorite

CSF B‐cell expansion in opsoclonus‐myoclonus syndrome: A biomarker of disease activity

By  

MOVEMENT DISORDERS, Vol. 19, Iss. 7, 2004-07 ,pp. : 770-777

John Wiley & Sons Inc

Access to resources Recommend Favorite